Method for pulmonary and oral delivery of pharmaceuticals

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 6616914
APP PUB NO 20010041190A1
SERIAL NO

09907393

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

In a powder formulation for use in a dry powder inhaler, a pharmaceutical acts as its own carrier, so that use of lactose or other excipients are not needed. The dry powder formulation has a single active pharmaceutical compound having two major populations in particle size distribution: microfine particles of the active pharmaceutical, of 1-10 microns in diameter, and larger carrier particles, also of the active pharmaceutical compound. The carrier particles provide a long acting, delayed onset, and optionally therapeutic effect via the GI tract, while the microfine particles provide a fast onset effect via the lung.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddressTotal Patents
MICRODOSE THERAPEUTX, INC.MONMOUTH JUNCTION, NJ53

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Schultz, Robert San Diego, CA 47 1286
Ward, Gary San Diego, CA 12 180

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation